ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,978Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 783

$1.1M Total Retail Price of All Prescriptions

Rank: 29 out of 783

914 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 914 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

30% of this provider’s 914 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

4% of this provider’s 9,574 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $231 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
MELOXICAM 1,352 1,031 10 1 38
HYDROCODONE-ACETAMINOPHEN 1,160 533 S3 2 7
GABAPENTIN 1,002 695 3 3
BACLOFEN 815 555 10 4 17
CLOPIDOGREL 637 552 5 33
CARISOPRODOL 482 131 R 6 42
ZOLPIDEM TARTRATE 433 283 7 20
NAMENDA 409 397 8 4
PHENYTOIN SODIUM EXTENDED 396 188 10 9 15
PLAVIX 368 322 10 45
TRAMADOL HCL 291 244 11 31
ACETAMINOPHEN-CODEINE 279 191 S3 12 60
ROPINIROLE HCL 271 215 13 10
DONEPEZIL HCL 267 251 14 2
CARBIDOPA-LEVODOPA 257 217 15 1
SIMVASTATIN 210 182 16 49
LYRICA 182 88 17 16
LEVETIRACETAM 151 83 18 5
NIASPAN 148 123 19 118
ATENOLOL 141 76 20 84
CARBAMAZEPINE 132 45 21 14
AMLODIPINE BESYLATE 129 111 22 51
SERTRALINE HCL 111 82 23 26
AMITRIPTYLINE HCL 110 22 R 24 19
HYDROMORPHONE HCL 109 27 S2 25 104
QUETIAPINE FUMARATE 106 81 26 23
CYCLOBENZAPRINE HCL 105 0 R 27 72
SUMATRIPTAN SUCCINATE 104 0 28 46
BENAZEPRIL HCL 102 80 29 135
DIVALPROEX SODIUM 100 36 30 22
PREDNISONE 99 49 31 72
OXCARBAZEPINE 99 61 31 37
MECLIZINE HCL 91 73 33 96
BUTALBITAL COMPOUND-CODEINE 90 27 S3 R 10 34 158
DIOVAN 89 61 35 98
PAROXETINE HCL 86 52 36 44
DILANTIN 83 44 37 48
CELEBREX 80 33 38 64
IBUPROFEN 79 29 39 53
OMEPRAZOLE 75 56 40 78
PROPRANOLOL HCL 74 53 41 28
LOSARTAN POTASSIUM 74 35 41 169
METHOCARBAMOL 70 46 R 43 123
ATORVASTATIN CALCIUM 70 60 43 69
SEROQUEL 70 39 43 54
TIZANIDINE HCL 68 16 46 56
TOPIRAMATE 68 12 46 6
OXYCODONE HCL 68 19 S2 46 52
MORPHINE SULFATE ER 65 0 S2 49 61
CYMBALTA 63 21 50 18
METFORMIN HCL 59 56 51 93
CLONAZEPAM 58 37 52 92
LEVOTHYROXINE SODIUM 54 42 53 82
OXYCODONE-ACETAMINOPHEN 54 23 S2 53 194
LACTULOSE 53 33 55 152
OXYCONTIN 52 15 S2 56 67
ALPRAZOLAM 50 34 57 204
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 15, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.